UDG Healthcare

Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors

Retrieved on: 
Tuesday, February 27, 2024
CFO, ICON, ICON PLC, Biotechnology, Jazz Pharmaceuticals, Bank, Female, Growth, Greencore, Audit committee, Organization, Patient, McKinsey & Company, Chair, ASOS, KPMG, UDG Healthcare, Nightclub

DUBLIN, Feb. 27, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors. Mr. Kennedy, Chair and Governor of the Bank of Ireland, has been appointed to the Jazz Board and will serve on the Audit Committee effective March 1, 2024. Peter Gray has decided not to seek re-election to the Jazz Board at the next Annual General Meeting, expected in July 2024.

Key Points: 
  • DUBLIN, Feb. 27, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors.
  • Mr. Kennedy, Chair and Governor of the Bank of Ireland, has been appointed to the Jazz Board and will serve on the Audit Committee effective March 1, 2024.
  • "We are thrilled to welcome Patrick to the Board," said Bruce Cozadd, chairman and CEO, Jazz Pharmaceuticals.
  • Mr. Kennedy brings over 30 years of experience to the Jazz Board with a successful track record across a range of global businesses.

Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors

Retrieved on: 
Tuesday, February 27, 2024
CFO, ICON, ICON PLC, Biotechnology, Jazz Pharmaceuticals, Bank, Female, Growth, Greencore, Audit committee, Organization, Patient, McKinsey & Company, Chair, ASOS, KPMG, UDG Healthcare, Nightclub

DUBLIN, Feb. 27, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors. Mr. Kennedy, Chair and Governor of the Bank of Ireland, has been appointed to the Jazz Board and will serve on the Audit Committee effective March 1, 2024. Peter Gray has decided not to seek re-election to the Jazz Board at the next Annual General Meeting, expected in July 2024.

Key Points: 
  • DUBLIN, Feb. 27, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors.
  • Mr. Kennedy, Chair and Governor of the Bank of Ireland, has been appointed to the Jazz Board and will serve on the Audit Committee effective March 1, 2024.
  • "We are thrilled to welcome Patrick to the Board," said Bruce Cozadd, chairman and CEO, Jazz Pharmaceuticals.
  • Mr. Kennedy brings over 30 years of experience to the Jazz Board with a successful track record across a range of global businesses.

Locus Robotics and United Drug Honoured at Robotics & Automation Awards for Best Use of Cobotics

Retrieved on: 
Thursday, November 9, 2023
Peter Hancock (professor), Sanitation, Cobot, UDC, Fulfillment, Food, Robotics, IEEE Robotics and Automation Award, Workplace, AMR, Environment, UDD, Partnership, Locus, Automation, Warehouse, UDG Healthcare

WILMINGTON, Mass., Nov. 9, 2023 /PRNewswire/ -- Locus Robotics, the market leader in autonomous mobile robots (AMRs) for Fulfilment warehouses, and United Drug, Ireland's largest pharmaceutical distribution company have been named winners of the "Best Use of Cobotics" award at the prestigious Robotics & Automation Awards in London.

Key Points: 
  • WILMINGTON, Mass., Nov. 9, 2023 /PRNewswire/ -- Locus Robotics, the market leader in autonomous mobile robots (AMRs) for Fulfilment warehouses, and United Drug, Ireland's largest pharmaceutical distribution company have been named winners of the "Best Use of Cobotics" award at the prestigious Robotics & Automation Awards in London.
  • The LocusBots' seamless integration with human workers has enabled United Drug to efficiently meet growing e-commerce demand and double productivity.
  • "Locus is honoured to receive this prestigious industry recognition alongside our customer, United Drug.
  • Locus and United Drug continue to make great strides in optimising and improving efficiency across all areas of their partnership.

Locus Robotics and United Drug Honoured at Robotics & Automation Awards for Best Use of Cobotics

Retrieved on: 
Thursday, November 9, 2023
Peter Hancock (professor), Sanitation, Cobot, UDC, Fulfillment, Food, Robotics, IEEE Robotics and Automation Award, Workplace, AMR, Environment, UDD, Partnership, Locus, Automation, Warehouse, UDG Healthcare

WILMINGTON, Mass., Nov. 9, 2023 /PRNewswire/ -- Locus Robotics, the market leader in autonomous mobile robots (AMRs) for Fulfilment warehouses, and United Drug, Ireland's largest pharmaceutical distribution company have been named winners of the "Best Use of Cobotics" award at the prestigious Robotics & Automation Awards in London.

Key Points: 
  • WILMINGTON, Mass., Nov. 9, 2023 /PRNewswire/ -- Locus Robotics, the market leader in autonomous mobile robots (AMRs) for Fulfilment warehouses, and United Drug, Ireland's largest pharmaceutical distribution company have been named winners of the "Best Use of Cobotics" award at the prestigious Robotics & Automation Awards in London.
  • The LocusBots' seamless integration with human workers has enabled United Drug to efficiently meet growing e-commerce demand and double productivity.
  • "Locus is honoured to receive this prestigious industry recognition alongside our customer, United Drug.
  • Locus and United Drug continue to make great strides in optimising and improving efficiency across all areas of their partnership.

Stack Capital Group Inc. Reports Q2-2023 Financial Results

Retrieved on: 
Thursday, August 3, 2023
IPO, DHL Supply Chain, Book value, DHL, ETR, History, FanDuel, Robotics, Commonwealth Bank, SpaceX, Sport, NYSE, UDG Healthcare, DPW, Neobank, Cryptocurrency, Security (finance), Uber, Visa, Nubank, Hopper, Starlink

Hopper - Stack Capital invested an additional US$2 million in Hopper, Inc., increasing the Company’s overall investment to US$8 million.

Key Points: 
  • Hopper - Stack Capital invested an additional US$2 million in Hopper, Inc., increasing the Company’s overall investment to US$8 million.
  • SpaceX - the launch business has continued to grow along with Starlink (wholly owned subsidiary), where global subscribers reportedly exceed 1.5 million.
  • Subsequent to the quarter, an additional tender was reportedly offered at a valuation of US$150 billion.
  • “We’re extremely pleased with the growth trajectory across our portfolio companies – highlighted by developments at Hopper, Locus Robotics, Prove Identity, and SpaceX,” said Jeff Parks, CEO of Stack Capital.

CXV GLOBAL AND PANACEA TECHNOLOGIES COMBINE TO CREATE LEADING PROVIDER OF SOLUTIONS OPTIMIZING LIFE SCIENCES OPERATIONS

Retrieved on: 
Wednesday, October 12, 2022
Laboratory, Engineering, Water Street, System, Efficiency, Abbott Laboratories, Organization, UDG, Multimedia, Investment, Technology, Panacea, Automation, Solution, Goal, Industry, Water Street, Milwaukee, CEO, Health, United Kingdom, Ownership, View, UDG Healthcare, Fine chemical, Pharmaceutical industry, Management, Crest, Amici miei – Come tutto ebbe inizio

CORK, Ireland and PHILADELPHIA, Oct. 12, 2022 /PRNewswire/ -- CXV Global, a strategic alliance comprised of European and U.S.-based Crest Solutions, Xyntek Incorporated and VistaLink, announced today that it is combining the three businesses under common ownership with Philadelphia-headquartered Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.

Key Points: 
  • The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.
  • Together, they offer life sciences companies a comprehensive portfolio of technologies and professional services that maximize the efficiency of their worldwide operations across their entire product life cycle.
  • CXV Global and Panacea Technologies offer a powerful platform of combined technologies and professional services that optimize life sciences' operations across product development, manufacturing, packaging and distribution.
  • CXV Global develops and delivers proprietary solutions to automate R&D, manufacturing, packaging and distribution operations for life sciences organizations.

CXV GLOBAL AND PANACEA TECHNOLOGIES COMBINE TO CREATE LEADING PROVIDER OF SOLUTIONS OPTIMIZING LIFE SCIENCES OPERATIONS

Retrieved on: 
Wednesday, October 12, 2022
Laboratory, Engineering, Water Street, System, Efficiency, Abbott Laboratories, Organization, UDG, Investment, Technology, Panacea, Automation, Solution, Goal, Industry, Water Street Historic District (Torrington, Connecticut), CEO, Health, United Kingdom, Ownership, UDG Healthcare, Fine chemical, Pharmaceutical industry, Management, Crest, Amici miei – Come tutto ebbe inizio

CORK, Ireland and PHILADELPHIA, Oct. 12, 2022 /PRNewswire/ -- CXV Global, a strategic alliance comprised of European and U.S.-based Crest Solutions, Xyntek Incorporated and VistaLink, announced today that it is combining the three businesses under common ownership with Philadelphia-headquartered Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.

Key Points: 
  • The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations' worldwide operations.
  • Together, they offer life sciences companies a comprehensive portfolio of technologies and professional services that maximize the efficiency of their worldwide operations across their entire product life cycle.
  • CXV Global and Panacea Technologies offer a powerful platform of combined technologies and professional services that optimize life sciences' operations across product development, manufacturing, packaging and distribution.
  • CXV Global develops and delivers proprietary solutions to automate R&D, manufacturing, packaging and distribution operations for life sciences organizations.

Above Phone and Presearch Partner on Secure Private Phone

Retrieved on: 
Thursday, August 25, 2022
Presearch, Above, Partnership, Theft, Privacy, Web browser, Text messaging, UDG Healthcare, VPN, Online shopping, Mobile phone

Above Phone will now ship with Presearch as default web browser and search engine.

Key Points: 
  • Midland, Ontario--(Newsfile Corp. - August 25, 2022) - Presearch is announcing that they will be the default search engine and default browser on Above Phone.
  • Presearch is a decentralized, private search engine and thus makes for an excellent partner for Above Phone.
  • Through a new collaboration with Presearch, the community-driven, decentralized search engine that respects user privacy, the Above Phone is now even more secure and private.
  • This partnership makes the Presearch search engine and web browser the default search and browsing experience for Above Phone users, bringing them a private and functional search experience right out of the box.

Above Phone Partners with Presearch on Secure, Private Phone

Retrieved on: 
Thursday, August 25, 2022
Presearch, Knowledge, Partnership, Theft, Organization, Privacy, Text messaging, UDG Healthcare, VPN, DeGoogle, Online shopping, Mobile phone

TORONTO, Aug. 25, 2022 /PRNewswire/ -- In an age of increased concern about surveillance, big tech tracking and security for crypto assets, Above Phone provides users with a private, secure phone that leverages the best in open source, privacy-focused software to create a full suite of apps to replace big tech.

Key Points: 
  • Through a new collaboration with Presearch , the community-driven, decentralized search engine that respects user privacy, the Above Phone is now even more secure and private.
  • This partnership makes the Presearch search engine and secure web browser app the default search and browsing experience for Above Phone users, bringing them a private and functional search experience right out of the box.
  • By setting Presearch as the default web browser and search engine, the Above Phone hides your searches from big tech and the surveillance state, all while providing world-class search results.
  • With the Above Phone powered by Presearch, theft of consumer data are blocked by default.

Meltmedia joins Evoke, Boosting Data-Driven Omnichannel and Marketing Technology Capabilities

Retrieved on: 
Wednesday, June 22, 2022
Solution, Industry, CTO, Culture, Creativity, Technology, CEO, UDG Healthcare, Business development, Clayton, Dubilier & Rice, Marketing, Justin, Health, Acquisition, VP, Organization, Video game, Public relations, Fine chemical, Evoke, Huntsworth

With core practice areas in digital transformation and omnichannel orchestration, Meltmedia partners with its clients to evolve their organizations and marketing infrastructure and lead the competition in today's digital-first landscape.

Key Points: 
  • With core practice areas in digital transformation and omnichannel orchestration, Meltmedia partners with its clients to evolve their organizations and marketing infrastructure and lead the competition in today's digital-first landscape.
  • The acquisition expands the strength and capabilities of Evoke's omnichannel marketing, digital transformation, and marketing technology and automation practices.
  • Reid Connolly, CEO of Evoke, said: "We are delighted to welcome Justin and the Meltmedia team to Evoke.
  • Meltmedia is a life sciences digital marketing agency focused on omnichannel excellence and digital execution.